A number of studies had shown that YTHDF1 was overexpressed in various cancers, including colorectal cancer, hepatocellular carcinoma, and breast cancer, and was closely related to the increased risk of these cancers (33–35). Here, YTHDF1 is linked to breast carcinoma.